Vitamin D3 in severe chronic obstructive pulmonary disease: from profound deficiency to functional recovery
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20261120Keywords:
Cholecalciferol, COPD, Dyspnoea, FEV1, Spirometry, Vitamin D3Abstract
Background: Chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow limitation and systemic inflammation. Vitamin D deficiency is prevalent among COPD patients and correlates with disease severity. This study evaluated the association between serum vitamin D3 levels and COPD severity, and the therapeutic effect of vitamin D3 supplementation.
Methods: A prospective interventional, single-blinded study enrolled 147 COPD patients. Baseline spirometry (FEV1), COPD assessment test (CAT), modified Medical Research Council (mMRC) scores, and serum vitamin D3 levels were recorded. Patients with severe and very severe COPD (GOLD stages 3 and 4, n=58) were randomized into group A (vitamin D3 supplementation) and group B (placebo). Follow-up spirometry and clinical scoring were performed at six months.
Results: Mean serum vitamin D3 levels decreased significantly as GOLD classification increased, from 44.77 ng/ml in GOLD 1 to 18.00 ng/ml in GOLD 4 (p<0.001). A strong negative correlation existed between CAT scores and vitamin D levels (r=-0.822, p<0.0001). Post-intervention, group A showed a highly significant improvement in mean FEV1 from 34.5% to 60.2% (p=0.001). Furthermore, vitamin D3 supplementation significantly improved mMRC and CAT scores.
Conclusions: Vitamin D deficiency is profoundly prevalent in advanced COPD. Targeted supplementation in deficient, severe COPD patients significantly improves FEV1, alleviates dyspnea, and reduces overall symptom burden, shifting patients to a moderate disease classification.
References
World Health Organization. Precision medicine: a path towards targeted, personalized and equitable care. 2026. Available at: https://apps.who.int/gb/ebwha/ pdf_files/EB158/B158_R2-en.pdf. Accessed on 13 January 2026.
Wang Y, He Y, Shi Y, Qian DC, Gray KJ, Winn R, et al. Aspiring toward equitable benefits from genomic advances to individuals of ancestrally diverse backgrounds. Am J Hum Genet. 2024;111(5):809-24.
Punjabi S, Misra S, Rippy MA, Grant SB, Galappaththi E, Lim T, et al. A conceptual framework for knowledge integration in cross-disciplinary collaborations. Environ Sci Policy. 2025;172:104197.
Sulemana M, Ibrahim A. Interdisciplinarity in the Social Sciences: Conceptual Foundations, Theoretical Perspectives, and Methodological Implications. Volume 4. 2026;4(1).
Mishra A. Designer Babies: Ethical, Scientific, and Social Implications. Int J Multidiscip Res. 2025;7(5):53722.
Maria W. Navigating the Intricacies of Reproductive Genetics: Ethical Dimensions Explored. J Fertil In vitro IVF Worldw Reprod Med Gent Stem Cell Biol. 2024;12:362.
Li X, He J, Yu M, Sun J. The efficacy of vitamin D therapy for patients with COPD: a meta-analysis of randomized controlled trials. Ann Palliat Med. 2020;9(2):286-97.
Rafiq R, Aleva FE, Schrumpf JA, Heijdra YF, Taube C, Daniels JM, et al. Prevention of exacerbations in patients with COPD and vitamin D deficiency through vitamin D supplementation (PRECOVID): a study protocol. BMC Pulm Med. 2015;15(1):106.
Zhu M, Wang T, Wang C, Ji Y. The association between vitamin D and COPD risk, severity, and exacerbation: an updated systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2016;11:2597-607.
Chang W, Whang JB, Lee JH. The strategic use of digital transformation capability: a meta-analytic approach. Eur J Innov Manag. 2026;16:1-26.
Yin K, Xu H, Yao W, Liu C, Chen Z, Cheung YH, et al. When Does Multimodal Learning Help in Healthcare? A Benchmark on EHR and Chest X-Ray Fusion. arXiv. 2026;11.
Verma G, Zhou J, Chandra M, Kumar S, Choudhury MD. A Framework for Situating Innovations, Opportunities, and Challenges in Advancing Vertical Systems with Large AI Models. arXiv. 2025;11.
Wang S, Yu Y. KG-Hopper: Empowering Compact Open LLMs with Knowledge Graph Reasoning via Reinforcement Learning. arXiv. 2026;11.
Kadir Y, Indarta PP. Vitamin D supplementation to reduce chronic obstructive pulmonary disease exacerbation: a scoping review. Int J Adv Med. 2025;12(2):250-6.
Rafiq R, Aleva FE, Schrumpf JA, Daniels JM, Bet PM, Boersma WG, et al. Vitamin D supplementation in chronic obstructive pulmonary disease patients with low serum vitamin D: a randomized controlled trial. Am J Clin Nutr. 2022;116(2):491-9.
Janssens W, Lehouck A, Carremans C, Bouillon R, Mathieu C, Decramer M. Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. Am J Respir Crit Care Med. 2009;179(8):630-6.
Khan DM, Ullah A, Randhawa FA, Iqtadar S, Butt NF, Waheed K. Role of Vitamin D in reducing number of acute exacerbations in Chronic Obstructive Pulmonary Disease (COPD) patients. Pak J Med Sci. 2017;33(3):610-4.
Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581-6.
Downloads
Published
How to Cite
Issue
Section
